![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Fenn P.
Publisher: Adis International
ISSN: 1170-7690
Source: PharmacoEconomics, Vol.16, Iss.2, 1999-08, pp. : 165-174
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Long-term cost savings with alteplase following stroke
Inpharma, Vol. 1, Iss. 1575, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
A Long-Term Comparison of Galantamine and Donepezil in the Treatment of Alzheimers Disease
By Wilcock G.
Drugs & Aging, Vol. 20, Iss. 10, 2003-01 ,pp. :